Wikidata

(Q39971422)

English

Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities

scientific article published in July 2008

In more languages

Statements

title
Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18560759
retrieved
16 September 2017
author name string
S Meidute Abaraviciene
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18560759
retrieved
16 September 2017
I Lundquist
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18560759
retrieved
16 September 2017
publication date
1 July 2008
1 reference
stated in
Europe PubMed Central
PubMed ID
18560759
retrieved
16 September 2017
page(s)
2256-2265
1 reference
stated in
Europe PubMed Central
PubMed ID
18560759
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39971422&oldid=1881508278"